Cargando…
Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes
Checkpoint inhibitors and oncolytic vaccine therapy have transformed the management of metastatic melanoma. This article presents the diagnosis and treatment landscape for metastatic melanoma, including clinicopathologic features of the disease, approved and emerging therapeutics, and strategies for...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857321/ https://www.ncbi.nlm.nih.gov/pubmed/33598326 http://dx.doi.org/10.6004/jadpro.2020.11.3.13 |
_version_ | 1783646425008046080 |
---|---|
author | Viereck, Amanda M. Olszanski, Anthony J. |
author_facet | Viereck, Amanda M. Olszanski, Anthony J. |
author_sort | Viereck, Amanda M. |
collection | PubMed |
description | Checkpoint inhibitors and oncolytic vaccine therapy have transformed the management of metastatic melanoma. This article presents the diagnosis and treatment landscape for metastatic melanoma, including clinicopathologic features of the disease, approved and emerging therapeutics, and strategies for integrating contemporary standard-of-care management practices. |
format | Online Article Text |
id | pubmed-7857321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Harborside Press LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-78573212021-02-16 Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes Viereck, Amanda M. Olszanski, Anthony J. J Adv Pract Oncol Meeting Reports Checkpoint inhibitors and oncolytic vaccine therapy have transformed the management of metastatic melanoma. This article presents the diagnosis and treatment landscape for metastatic melanoma, including clinicopathologic features of the disease, approved and emerging therapeutics, and strategies for integrating contemporary standard-of-care management practices. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857321/ /pubmed/33598326 http://dx.doi.org/10.6004/jadpro.2020.11.3.13 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Meeting Reports Viereck, Amanda M. Olszanski, Anthony J. Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes |
title | Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes |
title_full | Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes |
title_fullStr | Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes |
title_full_unstemmed | Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes |
title_short | Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes |
title_sort | creating clarity in metastatic melanoma: optimizing treatment and improving outcomes |
topic | Meeting Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857321/ https://www.ncbi.nlm.nih.gov/pubmed/33598326 http://dx.doi.org/10.6004/jadpro.2020.11.3.13 |
work_keys_str_mv | AT viereckamandam creatingclarityinmetastaticmelanomaoptimizingtreatmentandimprovingoutcomes AT olszanskianthonyj creatingclarityinmetastaticmelanomaoptimizingtreatmentandimprovingoutcomes |